3-Chlorotoluene
| Title | Journal |
|---|---|
| Structural and spectroscopic analysis of the kinase inhibitor bosutinib and an isomer of bosutinib binding to the Abl tyrosine kinase domain. | PloS one 20120101 |
| N-(4-Chloro-2-methyl-phen-yl)maleamic acid. | Acta crystallographica. Section E, Structure reports online 20111201 |
| Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents. | European journal of medicinal chemistry 20111001 |
| Metal-organic framework MIL-101(Cr) for high-performance liquid chromatographic separation of substituted aromatics. | Analytical chemistry 20110915 |
| Molecular structure and vibrational spectra of o-chlorotoluene, m-chlorotoluene, and p-chlorotoluene by ab initio HF and DFT calculations. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110301 |
| Allosteric interactions between the myristate- and ATP-site of the Abl kinase. | PloS one 20110101 |
| 3,5-Bis(4-fluoro-phen-yl)-1-phenyl-4,5-dihydro-1H-pyrazole. | Acta crystallographica. Section E, Structure reports online 20100801 |
| Enhancement of hydrophobic interactions and hydrogen bond strength by cooperativity: synthesis, modeling, and molecular dynamics simulations of a congeneric series of thrombin inhibitors. | Journal of medicinal chemistry 20100311 |
| Characterization of dasatinib and its structural analogs as CYP3A4 mechanism-based inactivators and the proposed bioactivation pathways. | Drug metabolism and disposition: the biological fate of chemicals 20090601 |
| Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib. | OncoTargets and therapy 20090101 |
| 1-(3-Chloro-benz-yl)-5-iodo-indoline-2,3-dione. | Acta crystallographica. Section E, Structure reports online 20081101 |
| 3-(3-Chloro-benz-yl)-1H-isochromen-1-one. | Acta crystallographica. Section E, Structure reports online 20081001 |
| N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptors. | Bioorganic & medicinal chemistry 20070715 |
| Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation. | Drug metabolism and disposition: the biological fate of chemicals 20070601 |
| Synthesis and antitubercular activity of quaternized promazine and promethazine derivatives. | Bioorganic & medicinal chemistry letters 20070301 |
| Chloromethylmuconolactones as critical metabolites in the degradation of chloromethylcatechols: recalcitrance of 2-chlorotoluene. | Journal of bacteriology 20050401 |
| 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors. | Biochemical pharmacology 20041115 |
| (Z)-7-Chloro-3-[(3-chlorophenyl)-methylidene]-4-p-tosyl-3,4-dihydro-2H-1,4-benzoxazine. | Acta crystallographica. Section C, Crystal structure communications 20010601 |